Usefulness of a single-assay chemiluminescence test (Tularaemia VIRCLIA IgG + IgM monotest) for the diagnosis of human tularemia. Comparison of five serological tests
- 222 Downloads
The aim of this work was to ascertain the usefulness of a new commercially-available single-assay chemiluminescence test (CHT) for the diagnosis of human tularemia (Tularaemia VIRCLIA IgG + IgM monotest, Vircell, Santa Fe, Granada, Spain). A total of 773 sera from 773 patients including 364 initial sera from patients with diagnosed tularemia, patients with suspected tularemia not confirmed (100), healthy people (152), patients with serology positive to Brucella (97), patients diagnosed with other infectious diseases (30), and patients diagnosed with autoimmune diseases (30) were included. All sera were tested by CHT, “in-house” microagglutination test (MAT), immunochromatographic test (ICT) (Virapid Tularaemia, Vircell, Santa Fe Granada, Spain), and “in-house” ELISA IgG, and ELISA IgM. Of the total initial sera, 334 (sensitivity 91.8%) were positive in the CHT, 332 (sensitivity 91.2%) in the MAT, 330 (sensitivity 90.7%) in the ICT, and 328 (sensitivity 90.1%) in the ELISA IgG and ELISA IgM tests. The specificity of the CHT was 96.7%; of the MAT, 100%; of the ICT, 98.7%; and of the ELISA IgG and ELISA IgM, 97.4%. In the group of patients with serology positive to Brucella, at least 12.4% of sera were positive in tularemia tests (12.4% in ELISA IgM, 13.4% in MAT, 14.4% in ICT, and 15.5% in CHT and ELISA IgG). In conclusion, CHT presents a sensitivity and specificity in early diagnosis of human tularemia, similar to MAT, ICT, and ELISA IgG and ELISA IgM. Its single assay design allows lower costs, especially in areas of low endemicity or inter-epidemic periods.
The authors wish to thank Prof. C. Nolan for collaborating with revising the English version.
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Compliance with ethical standards
Conflicts of interest
We declare no conflicts of interest.
Ethical approval and informed consent
Written informed consent was taken by the participants and the study was approved by the Ethics Committee of the Valladolid Clinic University Hospital and the Faculty of Medicine of the University of Valladolid (reference CEIC-PI-16-478). All sera were anonymized in relation to patient data.
- 1.WHO (2007) WHO Guidelines on Tularaemia: epidemic and pandemic alert response. WHO Press, Geneva http://www.who.int/csr/resources/publications/WHO_CDS_EPR_2007_7.pdf Google Scholar
- 7.Centro Nacional de Epidemiología (Instituto de Salud Carlos III) (1997) Brote de tularemia en Castilla y León. BES 5:249–252Google Scholar
- 8.Consejería de Sanidad (Junta de Castilla y León Spain) (2007) Informe sobre la situación epidemiológica de los casos de tularemia en Castilla y León. Año 2007 Consejería de Sanidad de la Junta de Castilla y León (Spain), Valladolid, Spain.http://www.saludcastillayleon.es/ciudadanos/es/enfermedades-problemas-salud/tularemia/vigilancia-epidemiologica-tularemia-castilla-leon2011
- 9.Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, JE MD, Osterholm MT, O’Toole T, Parker G, Perl TM, Russell PK, Tonat K, for the Working Group on Civilian B (2001) Tularemia as a biological weapon: medical and public health management. JAMA 285(21):2763–2773CrossRefPubMedGoogle Scholar
- 10.Penn RL (2015) Francisella tularensis (Tularemia). In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. Elsevier, Churchill Livingstone, Philadelphia, pp 2590–2602Google Scholar
- 13.Centers for Disease Control and Prevention (1997) Case definitions for infectious conditions under public health surveillance. MMWR 46:(No. RR-10)Google Scholar
- 20.Porsch-Ozcurumez M, Kischel N, Priebe H, Splettstosser W, Finke E-J, Grunow R (2004) Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for serological diagnosis of tularemia. Clin Diagn Lab Immunol 11(6):1008–1015PubMedPubMedCentralGoogle Scholar
- 21.Splettstoesser W, Guglielmo-Viret V, Seibold E, Thullier P (2010) Evaluation of an immunochromatographic test for rapid and reliable serodiagnosis of human tularemia and detection of Francisella tularensis-specific antibodies in sera from different mammalian species. J Clin Microbiol 48(5):1629–1634CrossRefPubMedPubMedCentralGoogle Scholar